You're signed outSign in or to get full access.
Eversept Partners, LP
Eversept Partners, L.P. is a New York-based hedge fund manager specializing in alpha-driven, low-net, fundamentally oriented, valuation-disciplined healthcare equity long/short strategies. The firm invests across all sub-sectors and market caps in the global healthcare industry, employing a long-term, valuation-driven research process and concentrating capital in its highest conviction ideas. The firm also opportunistically invests outside healthcare and may use leverage, options, and event-driven strategies.
Investment Strategy
Eversept employs a fundamental, long-term, valuation-driven approach, focusing on both long and short equity positions in healthcare and, opportunistically, other sectors. The firm is not constrained by diversification requirements and may concentrate assets in a limited number of high-conviction positions. Strategies include exploiting inefficiencies, short-term anomalies, and event-driven opportunities. The firm uses leverage, options, ETFs, convertible securities, and may invest in private placements or across geographies and asset classes as opportunities arise.
Latest 13F Filing Activity
Eversept Partners, LP filed their most recent 13F report on Jun 30, 2025 disclosing 66 equity positions and 1 options positions with a total 13F market value of $1B. The fund increased holdings in Vaxcyte Inc., Unitedhealth Group Inc., Illumina Inc. among other positions. Eversept Partners, LP reduced exposure to Neurocrine Biosciences Inc., GSK PLC, Healthequity Inc. among others.
Top Holdings
Equity Positions (66)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
N NTRA | NATERA INC | 12.37% | $134.5M | 796,375 | $44.18 | $168.94 | +$8.2M |
G GSK | GSK PLC | 7.92% | $86.1M | 2,242,388 | $34.72 | $38.40 | -$15.5M |
V VERA | VERA THERAPEUTICS INC | 5.16% | $56.1M | 2,383,055 | $17.49 | $23.56 | +$10.5M |
P PCVX | VAXCYTE INC | 3.88% | $42.2M | 1,298,514 | $39.10 | $32.51 | +$21.2M |
H HCA | HCA HEALTHCARE INC | 3.52% | $38.3M | 99,983 | $290.12 | $383.10 | -$14.4M |
Options Positions (1)
| Ticker | Security | Action | Type | Notional Value | Contracts | Underlying Price | Premium Paid | Change (Contracts) | Change (Value) |
|---|---|---|---|---|---|---|---|---|---|
Q QQQ | INVESCO QQQ TR | Bought | Put | $95.0M | 1,722 | $551.64 | $435.74 | +486 | +$37.0M |
Industry Allocation
Investment Team (2)
| Name | Role | Location | |
|---|---|---|---|
 | Analyst | New York, NY , United States | |
 | Analyst | New York, NY , United States |
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more